Definitive Contract 36C25920C0010
- Not listed
- The U.S. Department of Veterans Affairs (VA) awarded a firm fixed price delivery order to Genmark Diagnostics, Inc., a for-profit manufacturer of molecular diagnostic testing equipment and supplies. The $125,500.96 contract is to provide the VA with the company's ePlex instrument and Respiratory Pathogen Panel tests to support COVID-19 detection efforts at VA hospitals and clinics. Genmark Diagnostics has delivered its diagnostic technologies, test kits, reagents, and related services to VA,...
- The Department of Veterans Affairs (VA) awarded a firm fixed-price contract to Genmark Diagnostics, Inc., a for-profit manufacturer of molecular diagnostic testing equipment and supplies, to provide the COVID EPLEX RESPIRATORY PATHOGEN PANEL 2, EUA test kit. The $398,257.50 contract does not have a set-aside designation and was issued by the VA's Veterans Health Administration under the Veterans Integrated Service Network 10. Through this contract, Genmark will deliver its ePlex sample-to-answer...
- This is a $180,909.48 firm fixed price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The contract is set aside for small businesses and runs through July 16, 2023. Genmark Diagnostics provides the VA with its ePlex instrument and Respiratory Pathogen Panel tests to support COVID-19 detection efforts, as well as other diagnostic technologies, test kits,...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $183,993 firm fixed price purchase order to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies, for the provision of the company's ePlex instrument and Respiratory Pathogen Panel tests to aid in COVID-19 detection efforts at VA facilities. This purchase order was awarded on November 4, 2020 and is scheduled for completion by November 4, 2021. Genmark Diagnostics holds...
- This federal contract award from the Department of Veterans Affairs (VA) was issued to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The $286,631.50 firm fixed price purchase order is for Genmark's SENSOR XT-ANALYZER, with a completion date of June 8, 2024. Genmark Diagnostics has held several federal contracts and blanket purchase agreements (BPAs) with the VA to provide its ePlex molecular diagnostic instruments, SARS-CoV-2 test kits, and...
- This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The contract is for the lease of Genmark's SX eSensor XT8 Analyzer, as well as the provision of associated test kit reagents. The contract has a firm fixed price of $102,600.00 and does not utilize any set-aside designations. Genmark Diagnostics has a history of providing diagnostic...
- This federal contract award to Genmark Diagnostics, Inc. is a Blanket Purchase Agreement (BPA) from the Department of Veterans Affairs Veterans Health Administration (VHA) Veterans Integrated Service Network 19. The BPA, valued at $256,223.20, is for the procurement of eSensor RVP test and eSensor HCVG Direct test kits to support diagnostic testing at VHA facilities. The contract has a completion date of September 30, 2019 and is a firm fixed price contract with no set-aside designation. Genmark...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies, to provide 500 units of EPLEX COVID-19 reagents for $435,678.75. This award is associated with the VA's broader efforts to acquire Genmark's ePlex instrument and Respiratory Pathogen Panel tests to aid in COVID-19 detection at VA hospitals and clinics. Genmark Diagnostics holds several...
- This firm fixed price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The contract, valued at $140,000.00, supports the VA's COVID-19 response efforts through the provision of Genmark's ePlex instrument and Respiratory Pathogen Panel tests to aid in detection of the virus. Genmark holds several federal IDVs and BPAs with the VA to supply...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order contract to Genmark Diagnostics, Inc., a for-profit manufacturer of molecular diagnostic testing equipment and supplies. The $185,500.00 contract is to provide EPLEX SYSTEM (2 TOWER), LASER PRINTER, UPS POWER KIT, and 110V EMERGENCY COVID items, with a completion date of September 15, 2020. The contract has a small business set-aside designation and is related to the Coronavirus...
This federal contract award to Genmark Diagnostics, Inc., a for-profit manufacturer of molecular diagnostic testing equipment and supplies, was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for GENMARK ESENSOR KITS AND SERVICE. The $163,335.00 firm fixed price contract provides the VA with Genmark's ePlex instruments, SARS-CoV-2 test kits, and related maintenance and support services to enable COVID-19 detection and other infectious disease testing at VA facilities. The contract has no set-aside designation. Genmark Diagnostics holds several indefinite delivery vehicles (IDVs) and blanket purchase agreements (BPAs) with the VHA to rapidly supply its proprietary molecular diagnostic technologies to aid in serving veteran populations, including a $1.15 million BPA for ePlex analyzers and SARS-CoV-2 test kits in Colorado and a nearly $1.1 million BPA for ePlex systems and reagents in Oklahoma.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | ($82k) | 5/10/22 | |
| P00003 | Funding Only Action | ($2k) | 4/15/21 | |
| P00002 | Funding Only Action | $82.5k | 10/1/20 | |
| P00001 | Exercise an Option | $0 | 9/14/20 | |
| Not listed | Not listed | $82.5k | 10/1/19 |